Noxopharm (ASX:NOX) has reported its lupus medication in development, SOF-SKN, has passed first-stage in vitro safety tests ...

When Aleta was first diagnosed with lupus, she wasn’t ready to share her diagnosis with anyone beyond her closest family and ...

Noxopharm (ASX:NOX) has announced that its SOF-SKN lupus medication has successfully passed a set of important preclinical ...

Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...

The following is a summary of “Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year ...

Preterm birth―defined as delivery before the 37th week of pregnancy—is one of the leading causes of infant deaths in the ...

The filmmaking duo behind the animated adventure film Kensuke's Kingdom talks to Deadline about the craftsmanship that ...

Thyroid problems are rapidly surging in pregnant women and are a major concern as they can affect the health of both the mother and the baby. The thyroid gland produces hormones that are responsible ...

Moreover, the patient had persistent negative test results for lupus anticoagulant and IgG ACAs, had low titers of IgM ACAs on one occasion, and had no history of thrombotic events; therefore ...

Management will participate virtually in a fireside chat at a time to be determined and one-on-one investor meetings on Tuesday, March 18th, 2025. Please check the Events section of the Investors page ...

Shizuoka Blue Revs out of the top four in the process, as the visitors powered to a 33-14 win at Yamaha Stadium yesterday.